Kay T. Yeung
ORCID: 0000-0002-0013-7002Also affiliated with University of California San Diego, Moores Cancer Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 9 papers. Top paper: “Datopotamab–deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial”.
Meghna S. Trivedi, Christina Yau, Rita Nanda, Hope S. Rugo, Marie Davidian +55 more
Jane Meisel, Christina Yau, Hope S. Rugo, Rita Nanda, Marie Davidian +52 more
Kay T. Yeung, Sharmistha Das, Herbert H. Samuels, Alexander A. Tinnikov
Erica Silva, Akshat Singhal, Marcus R. Kelly, Kate Licon, I. Panagiotou +9 more
Alex P. Farfel, Kathryn E. Luker, Barbara A. Parker, Kay T. Yeung, Gary D. Luker +2 more
Xiaoyu Zhao, Patrick D. Wall, Emily So, G. Calderini, Alexander Partin +17 more
Alex P. Farfel, Kathryn E. Luker, Barbara A. Parker, Kay T. Yeung, Gary D. Luker +2 more
Kay T. Yeung, Sainath Mamde, Kate Ching‐Ju Lin, Armin Gandhi, Xue Lei +5 more
Kevin Kalinsky, Christina Yau, A. Jo Chien, Judy C. Boughey, Erica Stringer-Reasor +15 more